Our Oral Solid Dose Manufacturing Services
Whether your product is a small molecule or a natural health product, our facilities offer a full suite of cGMP-compliant services tailored to your formulation and development specifications. We specialize in formulation prototyping, batch production for clinical trials, and comprehensive analytical support.
Services Overview
Formulation Development & Prototyping
Small molecule and natural health products in solid oral dosage forms including capsules, soft gels, gummies, pills and tablets—including uncoated, film-coated, oral dissolving tablets (ODT) and capsules.
Throughput & Scale
Production capabilities of over 2,000 units/hour, suitable for Phase 1 & 2 clinical trials with batch sizes up to 10 kg.
cGMP Production
Full compliance with current Good Manufacturing Practices (cGMP) for oral solid dose at every stage of manufacturing up to phase 2 clinical trials.
Packaging & Labelling
Bottles and blister packs with labelling capacity of up to 10,000 units/day.
Stability Studies
Comprehensive shelf-life testing and long-term stability strategies.
Licensing & Compliance
Health Canada Drug Establishment License, Health Canada Licenses for Restricted Substances, Health Canada Cannabis License and Health Canada License for Natural Health Products
Did you find the service that meets your needs?
Start your journey with us.
Get In TouchContract Development Manufacturing Services & Facilities
Clinical Trial Manufacturing
Our CDMO services are supported by two key facilities—the Drug Development and Innovation Centre in the Katz Group Centre at the University of Alberta and the Biotechnology Business Development Centre (BBDC). Together, they offer flexibility in formulation, packaging, and labeling; ideal for early-stage oral dosage form development.
Key Facility Features Supporting Clinical Manufacturing
Drug Development & Innovation Centre (Katz)
- Manufacturing for tablets, capsules, and other solid oral dosage forms
- Throughput: Over 2,000 units/hour
- Formulation prototyping for synthetic and biologic inputs
- Packaging formats: bottles (up to 2,000 x 50/100 mL) and blister packs
- Labelling: up to 10,000 units/day
- Stability studies to support shelf-life and formulation refinement
- Suitable for Phase 1 & 2 clinical supply
- Testing for raw materials, APIs, and finished drug products
- Specialization in liquid and solid dosage forms, emulsions, and suspensions
- GC-MS for residual solvents and small molecule analysis
- HPLC and UPLC systems
- Dissolution systems, FTIR, UV/VIS, Viscosimeter
- KF Titration, TOC measurement
- Particle size distribution tools
- Stability chambers with diverse temperature and humidity settings
BBDC – Quality Control Laboratory
(Launching Q1 2026)
- Manufacturing for tablets, capsules, and other solid oral dosage forms
- Throughput: Over 2,000 units/hour
- Formulation prototyping for synthetic and biologic inputs
- Packaging formats: bottles (up to 2,000 x 50/100 mL) and blister packs
- Labelling: up to 10,000 units/day
- Stability studies to support shelf-life and formulation refinement
- Suitable for Phase 1 & 2 clinical supply
- Testing for raw materials, APIs, and finished drug products
- Specialization in liquid and solid dosage forms, emulsions, and suspensions
- GC-MS for residual solvents and small molecule analysis
- HPLC and UPLC systems
Contract Development Manufacturing Services & Facilities
Commercial-Scale API Manufacturing
While our current Oral Solid Dose capabilities focus on clinical-phase production, we do offer commercial-scale manufacturing of small molecule Active Pharmaceutical Ingredients (APIs) that support your oral drug development program. Explore how we support commercial API production in GMP environments, with scalability and regulatory alignment built in.
Meet Our Senior Leaders and Contacts
Allan Aginski
Senior VP, Special Projects & Manufacturing
Read bioabout Allan Aginski Allan Aginski
Senior VP, Special Projects & Manufacturing
Allan is a life sciences supply chain and manufacturing specialist with nearly 40 years of experience. He has established and run commercial life sciences company production facilities around the world, including for companies such as Abbott, Merck, and Genpharm. He has been responsible for the establishment of dozens of products in over 24 countries.
Hans Bauer
VP, Technical Operations
Read bioabout Hans Bauer Hans Bauer
VP, Technical Operations
Hans brings over 25 years of experience in pharmaceutical manufacturing and quality, having worked with leading pharmaceutical companies in Europe, including Lonza, Sandoz (Novartis), Acino, and Akorn. He has a proven track record in managing large teams, complex projects, and overseeing comprehensive operations.
Hans has strong expertise in developing and implementing robust quality systems that meet stringent regulatory standards across several countries, including the US, EU, and Switzerland. His production expertise includes API-small molecule manufacturing, peptide chemical and biotechnology manufacturing, as well as the production of solid and semi-solid forms and sterile manufacturing.
Shawn Couch
Director, Business Development
Read bioabout Shawn Couch Shawn Couch
Director, Business Development
Shawn Couch is a seasoned business development and key account management professional with over 20 years of experience in the North American pharmaceutical industry. With a strong track record of surpassing sales targets, he has expertise in drug substance and drug products, including solid oral, and injectables. His career includes business development roles at Corden Pharma, Fabricca Italiana Sintetici and ACIC Fine Chemicals, where he played a pivotal role in expanding market presence and increasing revenue.
Vijay Somayaji
Sr. Director, Product Development & Quality
Read bioabout Vijay Somayaji Vijay Somayaji
Sr. Director, Product Development & Quality
Vijay has over 30 years experience in biotech research and development and QA/QC. With a PhD in Chemistry and post-doctoral work under Nobel Laureate Dr. H. C. Brown, Vijay has served in director level roles at Biomira, AltaRex, Novolytic, and Virexx. As an experienced QA, Vijay has supported product development for dozens of clinical programs taking place at sites around the world.
Daniel Trepanier
Executive Scientist, Preclinical Development
Read bioabout Daniel Trepanier Daniel Trepanier
Executive Scientist, Preclinical Development
Over 25 years in the pharmaceutical industry. Experienced in pharmaceutical development including drug discovery, analytical and bioanalytical method development and analysis, preclinical pharmacokinetic, toxicological and toxicokinetic studies, formulation development, drug manufacturing and preclinical/clinical supply, preparation of preclinical regulatory submissions, interfacing with contract research organizations and patent attorneys. Real world experience in all aspects of drug development required to successfully move a drug from discovery, through myriad regulatory agency required studies, to Clinical Phase I/II status.
End-to-End Manufacturing Support
We provide comprehensive manufacturing solutions from preclinical stages to large-scale commercial production. Our integrated approach, combined with our Early Discovery & Development, Regulatory and Quantitative Solutions (QS) teams, ensures a seamless experience at every step of the development journey.
Discover CRO Services
Ready to take your life sciences innovation to the next level?
Contact us today for a free discovery consultation to determine how we can bring your idea to market together.